|
C2ORF56 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.62459995140574E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.23579999964119E-07 |
| Normal-vs-Stage2 |
3.216800E-03 |
| Normal-vs-Stage3 |
9.900500E-03 |
| Normal-vs-Stage4 |
2.483800E-01 |
| Stage1-vs-Stage2 |
3.224800E-01 |
| Stage1-vs-Stage3 |
6.411800E-01 |
| Stage1-vs-Stage4 |
9.991400E-01 |
| Stage2-vs-Stage3 |
6.994800E-01 |
| Stage2-vs-Stage4 |
6.232000E-01 |
| Stage3-vs-Stage4 |
8.376200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.72099999701447E-08 |
| Normal-vs-AfricanAmerican |
2.213200E-04 |
| Normal-vs-Asian |
8.134400E-02 |
| Caucasian-vs-AfricanAmerican |
9.837800E-01 |
| Caucasian-vs-Asian |
9.342200E-02 |
| AfricanAmerican-vs-Asian |
1.317040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58870000044331E-07 |
| Normal-vs-Female |
1.75739999996871E-06 |
| Male-vs-Female |
1.594400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.192300E-02 |
| Normal-vs-Extreme_Weight |
4.45960000000634E-05 |
| Normal-vs-Obese |
7.69740000000629E-05 |
| Normal-vs-Extreme_Obese |
3.301000E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.787400E-01 |
| Normal_Weight-vs-Obese |
4.176000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.572000E-02 |
| Extreme_Weight-vs-Obese |
8.975800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.383830E-01 |
| Obese-vs-Extreme_Obese |
1.396610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.210300E-04 |
| Normal-vs-Age(41-60Yrs) |
9.02139996039608E-09 |
| Normal-vs-Age(61-80Yrs) |
1.76530999999036E-05 |
| Normal-vs-Age(81-100Yrs) |
9.182800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.696400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.199670E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.036400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.384160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.126080E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.922000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.48580045436597E-10 |
| Normal-VS-Type2 PRCC |
7.499800E-02 |
| Normal-VS-KIRP CIMP |
2.722900E-03 |
| Normal-VS-Unclassified PRCC |
9.169800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.476100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.917010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.094000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.563600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.152400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.047600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.916730E-03 |
| Normal-vs-N1 |
1.930370E-02 |
| Normal-vs-N2 |
4.738200E-01 |
| N0-vs-N1 |
9.215800E-01 |
| N0-vs-N2 |
7.152200E-01 |
| N1-vs-N2 |
6.834600E-01 |
|
|
